Acute respiratory illness due to EV-D68 increased in late summer 2022

New study highlights sexual problems for young women who’ve had cancer
30 September 2022
ALS drug wins FDA approval despite questionable data
30 September 2022

Acute respiratory illness due to EV-D68 increased in late summer 2022

In late summer 2022, for children and adolescents, there was an increase in acute respiratory illness (ARI) resulting from enterovirus (EV)-D68 in the United States, according to research published in the Sept. 27 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Comments are closed.